← Back to Search

Leukotriene Receptor Antagonist

Montelukast Therapy on Alzheimer's Disease

Phase 2
Waitlist Available
Led By Ihab Hajjar
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 year

Summary

This trial tests montelukast, a medication usually used for asthma, on people with early Alzheimer's disease. The goal is to see if reducing brain inflammation can help improve memory and thinking. Participants will be treated for several months. Montelukast is commonly used to treat asthma and seasonal allergies, and it has shown potential in reducing neuro-inflammation, which is a hallmark of Alzheimer's disease.

Eligible Conditions
  • Alzheimer's Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Neuropsychiatric Inventory Questionnaire (NPI-Q) Score
Number of Discontinuations From Montelukast
Number of Participants With Any Gastrointestinal (GI) Symptoms
+4 more
Secondary study objectives
CSF Amyloid
CSF Tau Levels
Clinical Dementia Rating (CDR) Score
+1 more

Side effects data

From 2005 Phase 4 trial • 99 Patients • NCT00189462
16%
Cold/Upper Respiratory Infection
10%
Diarrhea
6%
Vomiting
100%
80%
60%
40%
20%
0%
Study treatment Arm
Montelukast
Placebo

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Montelukast GroupExperimental Treatment1 Intervention
Montelukast (10, 20, or 40 mg)
Group II: Placebo GroupPlacebo Group1 Intervention
Matched placebo pill
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Montelukast
2008
Completed Phase 4
~15460

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,708 Previous Clinical Trials
2,607,452 Total Patients Enrolled
Ihab Hajjar5.02 ReviewsPrincipal Investigator - Emory University
Emory University
~5 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top